Press release
Unlock Opportunities in Neurodegenerative Therapeutics Market | AI-Driven Diagnosis & Novel Drug Collaborations 2025
Neurodegenerative Disease Therapeutics Market
Download your FREE sample report: https://www.datamintelligence.com/download-sample/neurodegenerative-disease-therapeutics-market?jd
Emerging Collaborations and Acquisitions Driving Change in the Neurodegenerative Disease Therapeutics Market by 2025
• In August 2025, Sanofi completed its $470 million acquisition of Vigil Neuroscience. This acquisition added VG-3927, a novel oral TREM2 agonist for Alzheimer's disease, now moving into Phase II trials, to Sanofi's early-stage neurology pipeline. The deal also included Vigil's preclinical neurodegenerative pipeline, but not its second clinical candidate, VGL101. This move notably expands Sanofi's capabilities in targeting neuroinflammation and microglial dysfunction in Alzheimer's research.
• In July 2025, PharmaDrug acquired up to 44% equity in Canurta Inc., a biotechnology company specializing in botanical therapeutics aimed at inflammation and unmet needs in neurodegenerative diseases. This acquisition enables PharmaDrug to broaden its portfolio into plant-derived medicines specifically for neurodegenerative indications, as you described.
Cutting-Edge Innovations Revolutionizing the Global Neurodegenerative Disease Therapeutics Landscape in 2025
• Precision and Biomarker-Based Therapies: Diagnostic advancements and companion diagnostics enable earlier, more individualized interventions, allowing for treatments tailored to a patient's specific disease trajectory.
• Emergence of Biologics and Gene-Based Treatments: Biologics, monoclonal antibodies, and next-generation gene or antisense oligonucleotide therapies are at the forefront, especially for rare or early-stage disease, helping address the root causes of neurodegeneration.
• Digital Health and AI: AI algorithms and digital tools are now integral for early detection, real-time monitoring, and accelerating the development of new therapeutics, all of which aid in customizing patient care.
• Pipeline Growth Through Partnerships: Collaboration between large pharmaceutical companies and agile biotech firms is fueling innovation, leading to new drugs that target immune pathways, protect mitochondria, and fight chronic brain inflammation.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neurodegenerative-disease-therapeutics-market?jd
Key Regional Factors Propelling Growth in the Neurodegenerative Disease Therapeutics Market for 2025
North America dominates this market, with a well-developed healthcare infrastructure, significant investment in neuroscience R&D, and a high burden of disorders like Alzheimer's and Parkinson's. The United States, in particular, is a leader in innovative therapies and public health initiatives to address the needs of its rapidly aging population.
Europe: With a strong clinical research tradition and government support, Europe is seeing growth in precision medicine and the availability of advanced treatments. Countries including Germany, France, and the UK are at the forefront, propelled by targeted funding for orphan diseases and aging-related neurodegenerative conditions.
The Asia Pacific region is witnessing the fastest growth, as countries such as China, India, and Japan grapple with rapidly aging populations and rising disease prevalence. Expanded diagnostic capabilities, greater public awareness, and collaborative ventures between local and global pharmaceutical companies are driving increased access to novel therapies.
Latin America and Middle East & Africa: These emerging markets are steadily improving access to diagnostics and treatments through government initiatives and international collaborations, despite challenges with affordability and infrastructure. Rising elderly populations and growing disease awareness are laying the groundwork for continued market expansion.
Request for 2 Days FREE Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg?jd
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a premier market research and consulting company, dedicated to delivering comprehensive business solutions that span research, analysis, and strategic guidance. Our team leverages proprietary insights, evolving industry trends, and the latest market developments to craft timely and impactful solutions tailored precisely to your organization's requirements. Our diverse offerings range from in-depth syndicated and custom market reports to hands-on consulting, all grounded in a rigorous research methodology. With a portfolio covering over 6,300 reports across more than 40 different industries, we empower over 200 businesses in more than 50 countries with accurate data, detailed market intelligence, and actionable recommendations, helping them make informed decisions and achieve sustainable growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlock Opportunities in Neurodegenerative Therapeutics Market | AI-Driven Diagnosis & Novel Drug Collaborations 2025 here
News-ID: 4137331 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Flowable Hemostats Market Growth 2025 | Robotic Surgery Integration & Personaliz …
The global market for Flowable Hemostats is witnessing robust expansion, valued at around US$825 million in 2024 and projected to surge to about US$1.5 billion by 2032, with a steady compound annual growth rate (CAGR) of 7.0% between 2025 and 2032, according to DataM Intelligence. Several driving forces are fueling this trajectory, notably the growing number of surgical procedures worldwide, a rise in traumatic injuries, and an aging population that…
Global Erythropoietin Drugs Market Forecast 2025-2032 | Long-Acting ESAs & Advan …
The Global Erythropoietin Drugs Market reached US$10.77 billion in 2024 and is expected to reach US$14.59 billion by 2032, growing at a CAGR of 7.9% during the forecast period 2025-2032, according to DataM Intelligence report. This market is driven by the rising prevalence of chronic diseases such as chronic kidney disease (CKD), cancer-associated anemia, and the growing geriatric population, all of which increase demand for effective anemia management. Emerging opportunities…
Explainable AI Market to Hit $22.1B by 2031, Driven by Demand for Transparency, …
Global Explainable AI Market reached US$ 5.2 Billion in 2023 and is expected to reach US$ 22.1 Billion by 2031, growing with a CAGR of 20.2% during the forecast period 2024-2031.
Explainable AI (XAI) encompasses techniques and tools designed to make AI-driven decisions transparent, traceable, and understandable to humans addressing trust, ethics, and regulatory compliance in sectors like finance, healthcare, and defense.
To Download Sample Report Here: https://www.datamintelligence.com/download-sample/explainable-ai-market?nrk
☛ Market Trends
✔ Global…
Voice Biometrics Market Trends: AI Integration, Fraud Prevention & Omnichannel G …
Voice Biometrics Market is growing at a CAGR of 20.6% in the forecast period (2024-2031)
Voice biometrics is a technology that uses a person's unique vocal characteristics to verify and authenticate identity. It analyzes various aspects of a voice sample such as pitch, tone, cadence, and pronunciation to create a digital voiceprint. This method is widely used in call centers, banking, healthcare, and government services for secure and frictionless authentication.
Unlock exclusive…
More Releases for Neurodegenerative
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate?
The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Neurodegenerative Disease Market: Trends, Growth, and Opportunities
Price- USD 1550, According to Statifacts, The global neurodegenerative disease market size is valued at approximately USD 52,200 million in 2024 and is projected to nearly double, reaching USD 1,03,350 million by 2034, with a robust compound annual growth rate (CAGR) of 7.1% during the forecast period.
The neurodegenerative disease market is witnessing unprecedented growth, driven by rising global prevalence, advances in medical technology, and increased investment in research and development.…
Novel Antibodies in Neurodegenerative Disease Treatment
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, represent some of the most challenging medical conditions due to their progressive nature and lack of effective treatments. Novel antibodies are emerging as promising therapeutic agents, offering targeted and innovative approaches to slow disease progression and improve patient outcomes. This article explores the role of novel antibodies in the treatment of neurodegenerative diseases, highlighting their mechanisms of action and therapeutic potential.
Download…
